Market Capitalization (Millions $) |
286 |
Shares
Outstanding (Millions) |
26 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
11 |
Cash Flow (TTM) (Millions $) |
1 |
Capital Exp. (TTM) (Millions $) |
0 |
Intelligent Medicine Acquisition Corp
Intelligent Medicine Acquisition Corp is a special purpose acquisition company (SPAC) focused on the healthcare sector, specifically in the intelligent medicine and digital health space.
The company formed with the purpose of raising funds through an initial public offering (IPO) to acquire an existing intelligent medicine or digital health company. It seeks to identify companies with promising technologies or solutions that can improve healthcare delivery, patient outcomes, and overall efficiency of the healthcare system.
Intelligent Medicine Acquisition Corp aims to leverage its industry expertise and network to identify suitable target companies, negotiate a merger or acquisition deal, and ultimately drive growth and value for its shareholders. The company likely has a team of healthcare professionals, investors, and advisors who evaluate potential acquisitions and perform due diligence to ensure a successful merger.
Once Intelligent Medicine Acquisition Corp identifies a target, it will execute a business combination, allowing the acquired company to become publicly traded. This process provides the target company with access to capital markets, increased visibility, and potential growth opportunities.
Overall, Intelligent Medicine Acquisition Corp's goal is to facilitate the growth and expansion of intelligent medicine and digital health companies by providing them with the necessary financial resources and strategic support.
Company Address: 9001 Burdette Rd Bethesda 20817 MD
Company Phone Number: 905-5834 Stock Exchange / Ticker: 0 IQMD
IQMD is expected to report next financial results on April 16, 2024. |
|
|